Redhill Biopharma (NASDAQ:RDHL) reported its Q1 earnings results on Thursday, June 23, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Redhill Biopharma reported an EPS of $0.03.
Revenue was down $2.34 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.28 which was followed by a 12.72% increase in the share price the next day.
Here's a look at Redhill Biopharma's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.33 | -0.21 | -0.12 | -0.34 |
| EPS Actual | -0.05 | -0.50 | -0.06 | -0.05 |
| Revenue Estimate | 24.08M | 24.52M | 25.02M | 22.70M |
| Revenue Actual | 22.07M | 21.61M | 21.50M | 20.57M |
To track all earnings releases for Redhill Biopharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
